Adaptogen triage in midlife — what's actually worth attention

The adaptogen market has expanded in a way that makes triage difficult. A typical wellness influencer's "longevity stack" now contains six to eight adaptogens, often combined in proprietary blends, often at sub-therapeutic doses. The category has commercialised faster than the evidence base has matured, and most of what people end up buying isn't what produced the trial results.

I get the question often enough that it's worth writing down the structure I use when patients ask about adaptogens for midlife — not as a recommendation to take any of them, but as a way of triaging the noise.

The four-question test

Before considering any adaptogen, four questions:

Are the basics in place? Sleep, movement, nutrition, stress practice, social connection. Adaptogens produce small effects that compound modestly with the basics and produce essentially nothing without them. The amount of effort required to dial in basics is meaningfully larger than the amount required to add a supplement, and the benefit per unit of effort is also dramatically larger.

Is there a specific situation this addresses? Generic "adaptogen for healthspan" is not a use case. "I'm in a sustained period of work stress and want help with sleep onset" is. The trials that produced the strongest results tested specific adaptogens for specific situations, in specific populations, for specific durations.

Will I actually take it consistently for the trial-relevant duration? Most adaptogen trials run 8–12 weeks. A bottle that sits in a drawer for two weeks and gets restarted erratically captures essentially none of the documented benefit.

Have I checked it against my medications and conditions? Several adaptogens have meaningful drug interactions or contraindications. This is the question most often skipped.

If the answer to all four is yes, here's how I sort the category.

The three-tier triage

Tier 1: ashwagandha and rhodiola. These are the two adaptogens with the strongest modern clinical research. Standardised extracts (KSM-66 or Sensoril for ashwagandha, standardised rosavin/salidroside extracts for rhodiola) at the doses used in the better trials. For a sustained-stress period with sleep difficulty: ashwagandha 300–600 mg, evening, 8–12 weeks. For mental fatigue under sustained workload: rhodiola 200–400 mg, morning, 8–12 weeks.

If a patient asks me what to consider, this is the tier I'd mention. Modest effects, reasonable safety profile in healthy adults outside pregnancy, well-tested.

Tier 2: holy basil, schisandra, astragalus, reishi. Each has traditional use of long standing and modern research that's reasonably supportive but thinner. I'd consider these for specific situations rather than general use — astragalus as a daily background tonic for someone interested in TCM-tradition framing, reishi for general adaptive support, schisandra for cognitive support during demanding periods.

I don't push these. They're useful in context, neither transformative nor inert.

Tier 3: most of the rest. Cordyceps, maca, eleuthero, goji, jiaogulan, He Shou Wu, the various proprietary "longevity blends" — interesting traditions, varying levels of mechanistic support, thin clinical evidence at the doses and forms typically marketed. Most of what's sold to wellness consumers under "adaptogen" branding sits in this tier.

I don't recommend against these — they're mostly safe, some have long traditional use, and individual response varies. I just wouldn't expect them to do much, and I'd want the basics dialled in first.

What I'd avoid

Two specific things I push back on when patients raise them:

"Adaptogen stacks" with five or six herbs at sub-therapeutic doses each. The combination evidence doesn't exist. The ingredients individually are typically below the doses that produced effects in trials. The result is most likely an expensive way to pee, with the small risk of an unforeseen interaction.

He Shou Wu taken continuously. It's a classical TCM jing tonic with traditional longevity claims. There are also documented hepatotoxicity cases with prolonged use of unprocessed forms. The risk-to-benefit profile doesn't justify daily long-term use for anyone I'd advise.

Where I sit, personally

I take ashwagandha occasionally during periods of sustained work stress, in 8-week cycles, when the basics are otherwise dialled in. I drink astragalus broth in winter — partly because the cohort signal for traditional Chinese tonic herbs taken in food matrices is reasonable, partly because it's pleasant. Otherwise, I don't run a daily stack.

That's the honest position. The category has a few things in it worth knowing about. Most of it is overhyped. None of it substitutes for sleep, movement, nutrition, stress practice, and connection — and most of it adds modest value at best, on top of those.

If you're reading this and considering an adaptogen for the first time: do the four-question test honestly. Pick one Tier-1 herb, one specific reason, one defined cycle. Source from a reputable supplier with third-party testing. Take it consistently for 8–12 weeks. Notice what changes and what doesn't. That's a defensible experiment.

What I'd avoid is what most consumers end up doing: a stack of seven herbs purchased on impulse, taken inconsistently, expected to produce a longevity effect that the basics aren't already producing.

The marketing has run far ahead of the evidence. The triage is straightforward if you keep the four questions in mind.

— Carmen